FDA Inspection 865923 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3007166613

The FDA completed an inspection of Octapharma Plasma, Inc. on February 4, 2014 in Newport News, VA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 4, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newport News, VA (United States)